Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Y (Kim, Yonghwan) | - |
dc.contributor.author | Spitz, GS (Spitz, Gabriella S. | - |
dc.contributor.author | Veturi, U (Veturi, Uma) | - |
dc.contributor.author | Lach, FP (Lach, Francis P.) | - |
dc.contributor.author | Auerbach, AD (Auerbach, Arleen | - |
dc.contributor.author | Smogorzewska, A (Smogorzewska, | - |
dc.date.accessioned | 2022-04-19T10:11:36Z | - |
dc.date.available | 2022-04-19T10:11:36Z | - |
dc.date.issued | 2013-01 | - |
dc.identifier.issn | 0006-4971 | - |
dc.identifier.issn | 1528-0020 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/147506 | - |
dc.description.abstract | SLX4, the newly identified Fanconi anemia protein, FANCP, is implicated in repairing DNA damage induced by DNA interstrand cross-linking (ICL) agents, topoisomerase I (TOP1) inhibitors, and in Holliday junction resolution. It interacts with and enhances the activity of XPF-ERCC1, MUS81-EME1, and SLX1 nucleases, but the requirement for the specific nucleases in SLX4 function is unclear. Here, by complementing a null FA-P Fanconi anemia cell line with SLX4 mutants that specifically lack the interaction with each of the nucleases, we show that the SLX4-dependent XPF-ERCC1 activity is essential for ICL repair but is dispensable for repairing TOP1 inhibitor-induced DNA lesions. Conversely, MUS81-SLX4 interaction is critical for resistance to TOP1 inhibitors but is less important for ICL repair. Mutation of SLX4 that abrogates interaction with SLX1 results in partial resistance to both cross-linking agents and TOP1 inhibitors. These results demonstrate that SLX4 modulates multiple DNA repair pathways by regulating appropriate nucleases. (Blood. 2013; 121(1): 54-63) | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | AMER SOC HEMATOLOGY | - |
dc.title | Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4 | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1182/blood-2012-07-441212 | - |
dc.identifier.scopusid | 2-s2.0-84872082435 | - |
dc.identifier.wosid | 000313130400012 | - |
dc.identifier.bibliographicCitation | BLOOD, v.121, no.1, pp 54 - 63 | - |
dc.citation.title | BLOOD | - |
dc.citation.volume | 121 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 54 | - |
dc.citation.endPage | 63 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.